ARTICLE | Company News
Flamel, Merck KGaA deal
October 25, 2010 7:00 AM UTC
Flamel will receive a €3 million ($4.2 million) milestone payment from Merck under a 2007 deal to develop an extended-release formulation of an undisclosed interferon-beta-1a using Flamel's Medusa pol...